Xylazine is an emerging issue across the United States, often used in conjunction with opioids and other substances. Public health professionals must be aware of Xylazine’s effects and how it complicates efforts to prevent and treat other substance use. This presentation summarizes the available research and data on xylazine use.

This presentation was originally delivered at the 2023 NPN Conference in Birmingham, AL on August 16th-17th.